Migration to injury sites

Migration to injury sites is a fundamental biological process, not a single molecular target. It represents the coordinated movement of various cell types (including stem cells, immune cells, and epithelial cells) toward damaged tissue in response to injury signals. This process involves multiple molecular mechanisms working in concert: The primary molecular pathway characterized involves the **SDF-1α (stromal cell-derived factor 1 alpha)/CXCR4 (CXC chemokine receptor 4)** interaction[1][2]. Following tissue injury, astrocytes and endothelial cells upregulate SDF-1α at the injury site, creating a chemotactic gradient. Neural stem cells and other reparative cells expressing CXCR4 respond to this gradient and migrate toward the damaged tissue[1]. This mechanism triggers intracellular signaling cascades involving p38 MAPK kinase, ribosomal S6 kinase, c-Jun, extracellular response kinase, and paxillin - all critical for cell migration[1]. The recruitment process involves several coordinated stages: mobilization from reservoirs (such as bone marrow) into circulation, homing to the injury site via chemotactic gradients, vascular rolling and adhesion, endothelial transmigration, and migration within the extracellular matrix[2]. Additional growth factors like VEGF and G-CSF play crucial roles in mobilizing and recruiting stem cells[2]. For epithelial wound healing, cells at the leading edge express higher levels of matrix metalloproteinases, pro-inflammatory molecules, genes controlling cytoskeletal remodeling, and cell adhesion molecules like integrin α5[3]. Migration is driven by actin polymerization, adhesion complex formation, and mechanical forces[4].

Other names

Cell homing to injuryInjury-directed cell migrationPathology-directed migrationStem cell recruitment to injury sites